The heme biosynthetic pathway plays a crucial role in N-MYC myeloid leukemias
Yu Fukuda(St. Jude Children's Research Hospital), John D. Schuetz(St. Jude Children's Research Hospital), Gerard C. Grosveld(St. Jude Children's Research Hospital), Yiping Fan(St. Jude Children's Research Hospital), Frédérique Zindy(St. Jude Children's Research Hospital), Bruce Fanshawe(St Thomas' Hospital), Laura J. Janke(St. Jude Children's Research Hospital), Ayten Kandilci(Gebze Technical University), Yao Wang(Chinese PLA General Hospital), Brian P. Sorrentino(St. Jude Children's Research Hospital), Geoffrey Neale(St. Jude Children's Research Hospital), Shinjiro Nagai(Pharmaceutical Biotechnology (Czechia)), Martine F. Roussel(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
|Genes & Development|1998|1.2k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853